57 percent of vaccinated COVID-19 patients hospitalized in first half of 2021 had mild or asymptomatic infections, study finds


A recent nationwide study may lead health ofificials to rethink how to analyze COVID-19 hospitalizations as a pandemic metric, The Atlantic reports.
After examining the electronic records for nearly 50,000 patients who had tested positive for COVID-19 at 100 Veterans Affairs hospitals across the United States between March 2020 and June 2021, researchers found that a significant number of the patients actually had mild or asymptomatic infections. Patients who required supplemental oxygen or registered a blood oxygen level below 94 were considered moderate to severe.
Until mid-January 2021, when the vaccine drive really gained steam and the Delta variant had yet to take hold, 36 percent of patients were considered mild or asymptomatic. But in the next six months, that figure jumped to 48 percent, while an ever greater proportion — 57 percent — of vaccinated patients, who make up a much smaller share of admissions to begin with, had less severe cases.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
There are probably a few explanations behind the data, per The Atlantic. Many of the patients may have been admitted to the hospital for an unrelated illness and tested positive upon entrance. Others may have been treated as a preventative measure because of comorbities, and some may simply may have just needed quick, relatively easy treatments before leaving.
Like all studies, there are caveats, The Atlantic notes. VA hospitals aren't nationally representative because there are few women and no children, and while Delta was around in the later months of the study, it wasn't at the level it is now, so the numbers may have changed since then. Still, the study further highlights the effectiveness of vaccines and suggests that nuance is necessary when looking at COVID-19 hospitalization data. Read more at The Atlantic.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
5 weather-beaten cartoons about the Texas floods
Cartoons Artists take on funding cuts, politicizing tragedy, and more
-
What has the Dalai Lama achieved?
The Explainer Tibet’s exiled spiritual leader has just turned 90, and he has been clarifying his reincarnation plans
-
Europe's heatwave: the new front line of climate change
In the Spotlight How will the continent adapt to 'bearing the brunt of climate change'?
-
Cytomegalovirus can cause permanent birth defects
The Explainer The virus can show no symptoms in adults
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts